Next-generation sequencing to find predictors for chemotherapy response in triple-negative breast cancer (TNBC)

被引:0
|
作者
Lips, Esther H.
Michaut, Magali
Mulder, Lennart
Besselink, Nicolle
Hoogstraat, Marlous L.
Koudijs, Marco J.
Voest, Emile E.
Bernards, Rene
Wesseling, Jelle
Wessels, Lodewyk F. A.
Rodenhuis, Sjoerd
机构
[1] Netherlands Canc Inst, Dept Mol Pathol, Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Mol Carcinogenesis, Amsterdam, Netherlands
[3] UMC Utrecht, Dept Med Oncol, Ctr Personalized Canc Treatment, Utrecht, Netherlands
[4] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[5] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1010
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Updates on Targeted Therapy for Triple-Negative Breast Cancer (TNBC)
    Noor Z.S.
    Master A.
    Current Breast Cancer Reports, 2018, 10 (4) : 282 - 288
  • [42] Information preferences of women with triple-negative breast cancer (TNBC).
    Swiger, Kathleen Dickerson
    Sendecki, Jocelyn A.
    Guglielmino, Janine E.
    Rugo, Hope S.
    Domchek, Susan M.
    Anders, Carey K.
    Stricker, Carrie Tompkins
    Nelson, Hillary C. M.
    Hanson, Arin Ahlum
    Dinerman, Hayley
    Henry, Catherine Creme
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology
    Weisman, Paul S.
    Ng, Charlotte Ky
    Brogi, Edi
    Eisenberg, Rachel E.
    Won, Helen H.
    Piscuoglio, Salvatore
    De Filippo, Maria R.
    Ioris, Rafael
    Akram, Muzaffar
    Norton, Larry
    Weigelt, Britta
    Berger, Michael F.
    Reis-Filho, Jorge S.
    Wen, Hannah Y.
    MODERN PATHOLOGY, 2016, 29 (05) : 476 - 488
  • [44] Is there a subset of patients with triple-negative breast cancer (TNBC) in whom adjuvant chemotherapy may be omitted?
    Li, Eric
    Goldbach, Macy
    Ombres, Christina
    Fayanju, Oluwadamilola
    Zhang, Jennifer
    Elmore, Leisha
    Nayak, Anupma
    Tchou, Julia
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 238 - 240
  • [45] Transcriptomic modification induced by the first cycle of neoadjuvant chemotherapy impacts response to treatment in triple-negative breast cancer (TNBC)
    Desmoulins, I.
    Chardin, D.
    Richard, C.
    Arnould, L.
    Boidot, R.
    Humbert, O.
    ANNALS OF ONCOLOGY, 2021, 32 : S494 - S494
  • [46] Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing
    Wang, Nan
    Li, Kun
    Huang, Wenfa
    Kong, Weiyao
    Liu, Xiaoran
    Shi, Weijie
    Xie, Feng
    Jiang, Hanfang
    Song, Guohong
    Di, Lijun
    Wang, Quanren
    Yu, Jianjun
    Li, Huiping
    CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (02) : 149 - 162
  • [47] Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing
    Nan Wang
    Kun Li
    Wenfa Huang
    Weiyao Kong
    Xiaoran Liu
    Weijie Shi
    Feng Xie
    Hanfang Jiang
    Guohong Song
    Lijun Di
    Quanren Wang
    Jianjun Yu
    Huiping Li
    ChineseJournalofCancerResearch, 2020, 32 (02) : 149 - 162
  • [48] Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer
    Anurag, Meenakshi
    Jaehnig, Eric J.
    Krug, Karsten
    Lei, Jonathan T.
    Bergstrom, Erik J.
    Kim, Beom-Jun
    Vashist, Tanmayi D.
    Huynh, Anh Minh Tran
    Dou, Yongchao
    Gou, Xuxu
    Huang, Chen
    Shi, Zhiao
    Wen, Bo
    Korchina, Viktoriya
    Gibbs, Richard A.
    Muzny, Donna M.
    Doddapaneni, Harshavardhan
    Dobrolecki, Lacey E.
    Rodriguez, Henry
    Robles, Ana I.
    Hiltke, Tara
    Lewis, Michael T.
    Nangia, Julie R.
    Shafaee, Maryam Nemati
    Li, Shunqiang
    Hagemann, Ian S.
    Hoog, Jeremy
    Lim, Bora
    Osborne, C. Kent
    Mani, D. R.
    Gillette, Michael A.
    Zhang, Bing
    Echeverria, Gloria V.
    Miles, George
    Rimawi, Mothaffar F.
    Carr, Steven A.
    Ademuyiwa, Foluso O.
    Satpathy, Shankha
    Ellis, Matthew J.
    CANCER DISCOVERY, 2022, 12 (11) : 2586 - 2605
  • [49] Gefitinib enhances response to chemotherapy in triple-negative Breast Cancer (BrCa)
    Corkery, B.
    O'Donovan, N.
    Clynes, M.
    Crown, J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 185 - 185
  • [50] Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics
    Fu Ou-Yang
    Pan, Mei-Ren
    Chang, Shu-Jyuan
    Wu, Chun-Chieh
    Fang, Shao-Yu
    Li, Chung-Liang
    Hou, Ming-Feng
    Luo, Chi-Wen
    LIFE SCIENCES, 2019, 238